Real-world clinical outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) in current immune-oncology (IO) and tyrosine kinase inhibitors (TKIs) era Meeting Abstract
| Authors: | Shah, N. J.; Sura, S.; Shinde, R.; Shi, J. X.; Perini, R. F.; Puneet, S.; Robert, N. J.; Vogelzang, N. J.; Motzer, R. J. |
| Abstract Title: | Real-world clinical outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) in current immune-oncology (IO) and tyrosine kinase inhibitors (TKIs) era |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900335 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.331 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 331 -- Meeting was conducted online as well as in person -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
